Next Article in Journal
Predictive Value of Reactogenicity for Anti-SARS-CoV-2 Antibody Response in mRNA-1273 Recipients: A Multicenter Prospective Cohort Study
Next Article in Special Issue
Humoral Immune Response to CoronaVac in Turkish Adults
Previous Article in Journal
Evaluation of Safety and Immunogenicity of a Recombinant Receptor-Binding Domain (RBD)-Tetanus Toxoid (TT) Conjugated SARS-CoV-2 Vaccine (PastoCovac) in Recipients of Autologous Hematopoietic Stem Cell Transplantation Compared to the Healthy Controls; A Prospective, Open-Label Clinical Trial
Previous Article in Special Issue
A Cost-Effectiveness Analysis of Pre-Exposure Prophylaxis to Avert Rabies Deaths in School-Aged Children in India
 
 
Article

Article Versions Notes

Vaccines 2023, 11(1), 119; https://doi.org/10.3390/vaccines11010119
Action Date Notes Link
article pdf uploaded. 3 January 2023 13:31 CET Version of Record https://www.mdpi.com/2076-393X/11/1/119/pdf-vor
article supplementary file uploaded. 3 January 2023 13:31 CET - https://www.mdpi.com/2076-393X/11/1/119#supplementary
article pdf uploaded. 3 January 2023 17:03 CET Updated version of record https://www.mdpi.com/2076-393X/11/1/119/pdf-vor
article xml file uploaded 11 January 2023 08:57 CET Original file -
article xml uploaded. 11 January 2023 08:57 CET Update https://www.mdpi.com/2076-393X/11/1/119/xml
article pdf uploaded. 11 January 2023 08:57 CET Updated version of record https://www.mdpi.com/2076-393X/11/1/119/pdf
article html file updated 11 January 2023 08:58 CET Original file -
article html file updated 7 March 2023 20:09 CET Update https://www.mdpi.com/2076-393X/11/1/119/html
Back to TopTop